Outbreak
Nearly 60% of COVID-19 cases spread by asymptomatic carriers, CDC finds
Regardless of whether you feel ill, wear a mask, wash your hands, stay socially distant and get a coronavirus test ...
‘Rare event’: Moderna’s COVID-19 vaccine does not pose major danger of allergic reactions
Among 4,041,396 [Moderna COVID vaccine] doses given over 21 days, a total of 10 cases of anaphylaxis were confirmed by ...
Coronavirus treatment breakthrough? Eli Lilly’s monoclonal antibody drug shows promise in preventing COVID-19 spread
In November, the antibody bamlanivimab was authorized for emergency use by the Food and Drug Administration in treating patients with ...
A dangerous stage in the evolution of the novel coronavirus is upon us with the discovery of “escape mutations”. Artificial intelligence may be our best response
Real life with COVID-19 is now scarier than anything a sci-fi writer could envision. So-called “escape mutations” that can turn ...
Here’s the skinny on the mutating coronavirus strains complicating the vaccine response
The new coronavirus has likely mutated countless times without attracting the attention of epidemiologists. But new strains identified in the ...
African countries appear ill prepared for crash vaccine distribution effort
According to [a World Health Organization] analysis, based on countries’ self-reporting, the African region has an average score of 33 ...
Empathy fatigue: The quickly rising global COVID death toll is too much for our brains to process
More tragedy doesn’t always elicit more empathy; it can counterintuitively bring about apathy. The magnitude of the death toll can ...
COVID-19 Vaccine Monitor: Kaiser Family Foundation tracks public confidence in vaccine distribution
Using a combination of surveys and qualitative research, [the Kaiser Family Foundation COVID-19 Vaccine Monitor] tracks the dynamic nature of ...
Infographic: The evolutionary history of the COVID-19 coronavirus
Reuters analysed over 185,000 genome samples from the Global Initiative on Sharing All influenza Data (GISAID), the largest database of ...
New UK COVID variant is not only more infectious – it appears to be more deadly
Public Health England, Imperial College London, the London School of Hygiene and Tropical Medicine and the University of Exeter have ...
Will we ever reach COVID ‘herd immunity’? ¾ of the population of the Brazilian Amazon capital Manaus has been infected but the coronavirus marches on
In September, a preprint appeared online with the startling results from a study of covid-19 antibodies in blood-bank samples from ...
‘Vaccine euphoria’: Why this may be the ‘end of the beginning’ not the ‘beginning of the end’
Exuberant headlines about vaccines — Now two! Millions more doses! — have grabbed attention, as have rightfully joyous social media photos ...
Over 60 years, vaccines have prevented 4.5 billion cases and saved 10 million lives. Now anti-vaxxers want to roll back the clock
The misleading claims Americans will soon hear about the newly released COVID-19 vaccines are nearly identical to claims made about smallpox ...
How the ‘Japan model’ – limited testing with robust contact tracing – kept the country from being initially overwhelmed by COVID-19
[At the beginning of the pandemic,] Japan went its own way, limiting tests to only the most severe cases as ...
Podcast: How do mRNA vaccines work and why were they developed so fast?
Geneticist Dr Kat Arney takes a look at the discovery of messenger RNA (mRNA) and finds out how mRNA vaccines ...
Recovery is elusive for this COVID longhauler
Since getting sick with the coronavirus in March, Mr. Long, 54, has fallen into a distressing new cycle — one ...
Most religious leaders at the head of the anti-abortion movement are backing COVID vaccines
The U.S. Conference of Catholic Bishops, which says fighting abortion is its “preeminent” priority, said last month that getting vaccinated ...
COVID-19 linked to early Alzheimer’s and other forms of cognitive decline
Decades of evidence from other respiratory viruses, along with observations of patients in recent months, suggests such infections may increase ...
There is a lot of misinformation about COVID, the available vaccines and their effectiveness. These 7 insights will help clear that up.
Since the beginning of the coronavirus pandemic, there have been many thousands of articles and commentaries published on almost every ...
Even after an apparent ‘full recovery’ from COVID, this 20-year-old student experienced heart failure and nearly died
Maddie Neville contracted COVID-19 in October while living in an apartment off-campus near Temple University. She developed only mild symptoms — some ...
Genetic engineering gave us COVID vaccines. Here’s how they work, and why you shouldn’t be frightened
We’ve all heard the conspiracy theories about COVID-19. Now a whole new set is emerging around COVID vaccines — and spreading ...
Immunity from serious cases of COVID-19 could last for years, emerging research shows
[A new] study, published January 6 in Science, contrasts with earlier findings that suggested covid-19 immunity could be short-lived, putting millions ...
Viewpoint: The COVID vaccine rollout isn’t going well in the US. Here’s what we need to change
[F]ew Americans can answer the basic question: When and where can I get vaccinated? The country needs a distribution strategy ...
Why Black Americans are among the largest group of COVID vaccine skeptics
[A]cross the U.S., only 32% of Black adults say they would definitely or probably take a COVID-19 vaccine, according to ...
$850,000 in Trump Administration PPP loans went to anti-vaccine activist groups
Five prominent anti-vaccine organizations that have been known to spread misleading information about the coronavirus received more than $850,000 in loans from ...
To beat COVID-19, we need a global vaccination effort. How is that going?
Even with several vaccines approved for emergency use, there remains the tremendous challenge of producing enough of them for the ...
Single-dose COVID vaccine by Johnson & Johnson/Janssen up next for approval
Among the multiple vaccine candidates around the globe, next up in the arsenal against COVID-19 is likely the single-dose Ad26.COV2.S ...
